...
首页> 外文期刊>BMC Biotechnology >Isolation and characterization of a Sca-1+/CD31- progenitor cell lineage derived from mouse heart tissue
【24h】

Isolation and characterization of a Sca-1+/CD31- progenitor cell lineage derived from mouse heart tissue

机译:小鼠心脏组织来源的Sca-1 + / CD31-祖细胞谱系的分离和鉴定

获取原文

摘要

Background Myocardial infarction remains the leading cause of mortality in developed countries despite recent advances in its prevention and treatment. Regenerative therapies based on resident cardiac progenitor cells (CPCs) are a promising alternative to conventional treatments. However, CPCs resident in the heart are quite rare. It is unclear how these CPCs can be isolated and cultured efficiently and what the effects of long-term culture in vitro are on their ‘stemness’ and differentiation potential, but this is critical knowledge for CPCs’ clinical application. Results Here, we isolated stem cell antigen-1 positive cells from postnatal mouse heart by magnetic active cell sorting using an iron-labeled anti-mouse Sca-1 antibody, and cultured them long-term in vitro. We tested stemness marker expression and the proliferation ability of long-term cultured Sca-1+ cells at early, middle and late passages. Furthermore, we determined the differentiation potential of these three passages into cardiac cell lineages (cardiomyocytes, smooth muscle and endothelial cells) after induction in vitro. The expression of myocardial, smooth muscle and endothelial cell-specific genes and surface markers were analyzed by RT-PCR and IF staining. We also investigated the oncogenicity of the three passages by subcutaneously injecting cells in nude mice. Overall, heart-derived Sca-1+ cells showed CPC characteristics: long-term propagation ability in vitro, non-tumorigenic in vivo, persistent expression of stemness and cardiac-specific markers, and multipotent differentiation into cardiac cell lineages. Conclusions Our research may bring new insights to myocardium regeneration, for which even a small number of biopsy-derived CPCs could be enriched and propagated long term in vitro to obtain sufficient seed cells for cell injection or cardiac tissue engineering.
机译:背景技术尽管最近在预防和治疗方面取得了进展,但心肌梗塞仍是发达国家死亡的主要原因。基于常驻心脏祖细胞(CPC)的再生疗法是传统疗法的有希望的替代方法。但是,常驻在心脏的CPC很少。目前尚不清楚如何有效地分离和培养这些CPC,长期体外培养对其“干性”和分化潜能有何影响,但这是CPC的临床应用的关键知识。结果在这里,我们使用铁标记的抗小鼠Sca-1抗体通过磁性活性细胞分选从出生后的小鼠心脏中分离了干细胞抗原1阳性细胞,并对其进行了长期体外培养。我们测试了干细胞标志物的表达以及长期培养的Sca-1 + 细胞在早期,中期和晚期传代的增殖能力。此外,我们确定了体外诱导后这三个通道向心肌细胞谱系(心肌细胞,平滑肌和内皮细胞)的分化潜能。通过RT-PCR和IF染色分析心肌,平滑肌和内皮细胞特异性基因和表面标志物的表达。我们还通过皮下注射裸鼠中的细胞研究了这三代的致癌性。总体而言,心脏来源的Sca-1 + 细胞具有CPC特征:体外长期繁殖能力,体内非致瘤性,茎干和心脏特异性标记物的持续表达以及向心脏的多能分化细胞谱系。结论我们的研究可能会为心肌再生带来新的见解,即使是少量活检衍生的CPC也可以在体外长期富集和繁殖,以获得足够的种子细胞用于细胞注射或心脏组织工程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号